Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Junhyoung Park"'
Publikováno v:
Cancer Research. 83:P6-11
Breast cancer stem cell (BCSC) is a subset of cancer cells that can dictate the tumor initiation, metastatic progression, and therapeutic resistance in BC. The eradication of this unusual population is emerging as a new paradigm in cancer treatment.
Autor:
SeungWon Song, Seokyoon Jeong, Sangwoo Park, Jungkee Choi, WoonHyuk Choi, No-Young Chung, Seongtae Jeong, Fan Jiang, Liang Cao, Le Hong, Junhyoung Park, Doohwan Kwak, Jongwon Lee, Harin Kim, Jiyoung Lee
Publikováno v:
DTCO and Computational Patterning II.
Autor:
Junhyoung Park
Publikováno v:
The Paek-San Society. 120:117-133
Publikováno v:
The American Journal of Sports Medicine. :036354652311663
Background: Lateral epicondylitis is a chronic tendinopathy of humeral origin of the common extensor tendon. Most patients show improvement after nonoperative treatment. However, 4% to 11% of patients require surgical treatment. Although corticostero
Autor:
Junhyoung Park, Kwang Hwa Jung, Dongya Jia, Sukjin Yang, Kuldeep S. Attri, Songyeon Ahn, Divya Murthy, Meron Ghidey, Somik Chatterjee, Diego A. Pedroza, Abha Tiwari, Suna Kim, Chad C. Creighton, Nagireddy Putluri, Jeffrey M. Rosen, José N. Onuchic, Andrei Goga, Benny A. Kaipparettu
Publikováno v:
Cancer Research. 83:294-294
Biguanides such as metformin are one of the most widely administered anti-diabetic drugs. Biguanides can suppress OXPHOS by inhibiting the complex-I activity of the mitochondrial electron transport chain (ETC). Though metformin recently generated lot
Autor:
Junhyoung Park
Publikováno v:
The Paek-San Society. 117:241-250
Autor:
Junhyoung Park, Junseop Byeon, Jihun Jang, MyeongGeun Ko, Namyoung Ahn, Mansoo Choi, Hyung‐Jun Song
Publikováno v:
Advanced Energy Materials. 13:2203012
Autor:
Sara Murphy, Matthew P Mullarkey, Upasana Sahu, Bangxing Hong, Cole Lewis, Miguel Diaz, Pamela Wenzel, Abu Hena Mostafa Kamal, Nagireddy Putluri, Junhyoung Park, Benny Kaipparettu, Balveen Kaur
Publikováno v:
Neuro-Oncology. 24:vii227-vii227
Glioblastoma Multiforme (GBM) is the most aggressive malignant primary brain tumor and has abysmal 5-year overall survival. With the approval of oHSV Imlygic by FDA for metastatic melanoma and more recently, conditional approval of G47Δ, marketed by
Autor:
Junhyoung Park
Publikováno v:
The Paek-San Society. 112:5-24
Autor:
Benny Abraham Kaipparettu, Kwang Hwa Jung, Dakota L. Jackson, Junhyoung Park, Jie Han, Arianne L. Theiss
Publikováno v:
The FASEB Journal. 32